Janus Contrarian Fund (JSVAX)
Investing Opportunistically in Non-Consensus Equity Ideas

SHARE CLASS

FUND FACTS (JSVAX)

Inception Date2/29/2000
NAV (As of 3/27/15 )$22.25
Total Net Assets (As of 2/28/15)$4.59B
Annual Expense Ratio
(As of fiscal year end 9/30/14)
GROSS 0.89%
NET 0.89%

Performance (As of 12/31/14)
1 Year17.32%
3 Year26.25%
5 Year13.48%
10 Year8.89%
Morningstar (As of 2/28/15)
CategoryLarge Blend
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Net expense ratios reflect the expense waiver, if any, Janus Capital has contractually agreed to through 2/1/16.

Straight Talk

Chapter 1 (1 of 4)

Contrarian Investing

Chapter 2 (2 of 4)

Change-factor Analysis

Chapter 3 (3 of 4)

Market Effects on Performance

Chapter 4 (4 of 4)

Macro Influences

Quarterly Commentary - Q4 2014

EXECUTIVE SUMMARY

U.S. equities notched gains during the period as numerous data points suggested the domestic economy was improving.

The Fund outperformed its benchmark.

We are seeing an increase in contrarian investment ideas from the number of spin-offs taking place in the market.

FUND MANAGEMENT

Daniel R. Kozlowski, CFA

Fund Manager since 2011
Industry since 1999